Resources Contact Us Home
Intracorporeal medicaments for photodynamic treatment of disease

Image Number 3 for United States Patent #7863047.

New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection. In another preferred embodiment, such medicaments are produced in various formulations including liquid, semisolid, solid or aerosol delivery vehicles.

  Recently Added Patents
Notification systems and methods that consider traffic flow predicament data
Debugging using code analysis
Systems and methods for electronic verification of vehicle insurance coverage
Data encoding and decoding apparatus and method thereof for verifying data integrity
Imidazole derivatives used as TAFIa inhibitors
Formation of an optical waveguide
Vectorization of program code
  Randomly Featured Patents
Viscose rayon and method of making same
Motion translation mechanism
Phase-stable concentrated fabric softeners containing borates
Trash bag support with collapsible legs
Meat mold or similar article
Patch-division unit for high-order surface patch rendering systems
Manufacture of battery plates
Method for drawing object that changes transparency
Method for forming a pattern on a surface of an aluminum extrusion